Stay Ahead with Real-Time Reagan-Udall Foundation Monitoring
Independent Agency
Document Statistics
Documents by Year
Documents by Type
The Reagan-Udall Foundation for the Food and Drug Administration (FDA) plays a crucial role in modernizing the development of medical, veterinary, food, and cosmetic products. Established under the Food and Drug Administration Amendments Act of 2007, the foundation serves to accelerate innovation and enhance product safety without the involvement of any federal employees on its board. Its influence extends across various industries, including pharmaceuticals, food safety, and cosmetics. Keeping up with updates from this foundation is vital for professionals in compliance, policy analysis, research and development, and strategic planning.
Why Monitor the Reagan-Udall Foundation?
Several stakeholders have significant interest in the ongoing activities and regulatory evolutions concerning the Reagan-Udall Foundation. These include:
-
Compliance Officers ensure that their organizations meet all regulatory requirements by staying informed about any new guidelines or rule changes initiated by collaborations facilitated by the Foundation.
-
Legal Teams benefit from early insights into policy shifts, allowing them to prepare for legal challenges and advise their organizations appropriately.
-
Research and Development (R&D) Managers can respond swiftly to innovation opportunities or regulatory changes that may impact product development timelines and strategies.
-
Policy Analysts require a deep understanding of the background and context of regulations stemming from the Foundation’s work to provide accurate policy recommendations.
Key Reasons to Monitor
- Stay Ahead of Policy Changes: Updates often involve regulatory changes or new initiatives that can significantly impact strategic directions for companies, especially in heavily regulated industries.
- Simplify Monitoring Efforts: With ongoing releases in the Federal Register, having a streamlined approach to track relevant notices can save time and effort.
- Respond to Open Comment Periods: Identifying when the comment periods open for new regulations or changes can be critical for stakeholder influence.
- Plan Strategically for Industry Shifts: Trends identified in the Foundation's publications may herald significant industry changes, requiring proactive strategy adjustments.
Recent Trends and Regulatory Impacts
The Foundation has recently emphasized enhancing public health initiatives and refining the safety standards of various consumer products. Agencies and industries involved in public health, safety testing, and product development closely monitor these updates to align their strategic initiatives accordingly.
How FedMonitor Can Help
In an era where regulatory compliance and strategic agility are paramount, being equipped with an AI-powered monitoring solution is essential. FedMonitor.com provides comprehensive coverage of the Reagan-Udall Foundation’s updates in the Federal Register, ensuring you receive:
- Real-Time Alerts: Instant notifications tailored to your specific interests and industries.
- Filtered Content: Filter updates to only receive what's relevant, ensuring you focus on the most impactful changes.
- Quick Relevance Understanding: Effortlessly gauge the applicability of rules and notices using our document summaries.
Additionally, our monitoring service supports popular integrations, allowing alerts to be sent directly to Slack, Microsoft Teams, Salesforce, email, or SMS. This ensures your team stays informed and can act swiftly when timely knowledge is crucial.
Learn more about how you can streamline your monitoring needs with FedMonitor. Our masterfully configured alerts help ensure that you never miss a critical development, giving you more time to focus on strategic initiatives.
Agency Details
-
Status:
Active
The Reagan-Udall Foundation operates as a private and independent non-profit organization according to its foundational mandate set by the Food and Drug Administration Amendments Act of 2007. It continues to serve its intended purpose of modernizing product development and enhancing safety, as indicated by the lack of information suggesting any change in its operational status.
Latest Documents
| Title | Type | Published |
|---|---|---|
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Administration Amendments Act of 2007, is announcing its annual public meeting. The purpose of this meeting is to provide an op...
|
Notice | Apr 14, 2016 |
|
The Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is requesting nominations for its Big Data for Patients (BD4P) Steering Committee. The Steering Commi...
|
Notice | Aug 06, 2015 |
|
The Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is requesting nominations for its PredicTox Steering Committee. The Steering Committee will provide o...
|
Notice | Jul 30, 2015 |
|
The Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is requesting nominations for its PredicTox Steering Committee. The Steering Committee will provide o...
|
Notice | Jul 24, 2015 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is requesting nominations for its Innovation in Medical Evidence Development and Surveillance (IMEDS) Steer...
|
Notice | May 08, 2015 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is requesting nominations for its Innovation in Medical Evidence Development and Surveillance (IMEDS) Scien...
|
Notice | May 08, 2015 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Administration Amendments Act of 2007, is announcing its annual public meeting. The purpose of this meeting is to provide an op...
|
Notice | Apr 21, 2015 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), published a document in the Federal Register of April 3, 2014, concerning the Foundation's Annual Open Public Meeting on May 14, 2014. The document contained the incorrect addres...
|
Notice | Apr 25, 2014 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is announcing an annual open public meeting. The Foundation will provide an overview of its history, projec...
|
Notice | Apr 03, 2014 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is requesting nominations for its Innovation in Medical Evidence Development and Surveillance (IMEDS) Steer...
|
Notice | Apr 23, 2013 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is announcing an annual open public meeting. The Foundation will provide an overview of its history, projec...
|
Notice | Apr 23, 2013 |
|
The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is announcing an annual open public meeting. The Foundation will provide an overview of its history, projec...
|
Notice | May 04, 2012 |
|
The Reagan-Udall Foundation, which was created by Title VI of the Food and Drug Administration Amendments of 2007, is publishing the bylaws that were adopted by its Board of Directors, for public comment.
|
Notice | Dec 22, 2009 |
No sub-agencies found.